The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden

Pieri, 2020, Country income is only one of the tiles: the global journey of antimicrobial resistance among humans, animals, and environment, Antibiotics (Basel), 9, 9 Sullivan, 2001, Effect of antimicrobial agents on the ecological balance of human microflora, Lancet Infect Dis, 1, 101, 10.1016/S1473-3099(01)00066-4 Cassini, 2019, Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis, Lancet Infect Dis, 19, 56, 10.1016/S1473-3099(18)30605-4 Fröding, 2019, Prediction of bloodstream infection caused by extended-spectrum β-lactamase-producing Enterobacterales in patients with suspected community-onset sepsis, Int J Antimicrob Agents, 53, 820, 10.1016/j.ijantimicag.2019.02.008 Paterson, 2004, “Collateral damage” from cephalosporin or quinolone antibiotic therapy, Clin Infect Dis, 38, S341, 10.1086/382690 Settle, 1998, Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam, Aliment Pharmacol Ther, 12, 1217, 10.1046/j.1365-2036.1998.00428.x Dong, 2020, Emerging superbugs: the threat of carbapenem resistant Enterobacteriaceae, AIMS Microbiol, 6, 176, 10.3934/microbiol.2020012 Woerther, 2018, Carbapenems and alternative β-lactams for the treatment of infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: what impact on intestinal colonisation resistance?, Int J Antimicrob Agents, 52, 762, 10.1016/j.ijantimicag.2018.08.026 Theuretzbacher, 2015, Reviving old antibiotics, J Antimicrob Chemother, 70, 2177, 10.1093/jac/dkv157 Kresken, 2021, Temocillin susceptibility in Enterobacterales with an ESBL/AmpC phenotype, Int J Antimicrob Agents, 57, 10.1016/j.ijantimicag.2020.106223 Giske, 2015, Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin, Clin Microbiol Infect, 21, 899, 10.1016/j.cmi.2015.05.022 Kuch, 2020, Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland, Eur J Clin Microbiol Infect Dis, 39, 1185, 10.1007/s10096-020-03844-5 Alexandre, 2018, Pharmacokinetics and pharmacodynamics of temocillin, Clin Pharmacokinet, 57, 287, 10.1007/s40262-017-0584-7 Mittermayer, 1985, Influence of temocillin on human bowel flora, Drugs, 29, 43, 10.2165/00003495-198500295-00010 Boon, 1985, Studies with temocillin in the hamster model of antibiotic-associated colitis, Drugs, 29, 57, 10.2165/00003495-198500295-00012 Chenouard, 2021, Impact of ceftriaxone and temocillin on fecal abundance of extended-spectrum β-lactamase producing Escherichia coli in a mouse model, PLoS One, 16, 10.1371/journal.pone.0248177 Balakrishnan, 2011, Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae, J Antimicrob Chemother, 66, 2628, 10.1093/jac/dkr317 Laterre, 2015, Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration, J Antimicrob Chemother, 70, 891, 10.1093/jac/dku465 Elvers, 2020, Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review, BMJ Open, 10, 10.1136/bmjopen-2019-035677 Kahan, 2014, Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?, BMC Med Res Methodol, 14, 20, 10.1186/1471-2288-14-20 De Vries-Hospers, 1985, Influence of temocillin on colonisation resistance and consequences for therapy, Drugs, 29, 227, 10.2165/00003495-198500295-00050 Burdet, 2019, Ceftriaxone and cefotaxime have similar effects on the intestinal microbiota in human volunteers treated by standard-dose regimens, Antimicrob Agents Chemother, 63, e02244, 10.1128/AAC.02244-18 Habayeb, 2015, Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit, Eur J Clin Microbiol Infect Dis, 34, 1693, 10.1007/s10096-015-2406-x Isendahl, 2019, Temporal dynamics and risk factors for bloodstream infection with extended-spectrum β-lactamase-producing bacteria in previously-colonized individuals: national population-based cohort study, Clin Infect Dis, 68, 641, 10.1093/cid/ciy539 Cornejo-Juárez, 2016, Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies, Support Care Cancer, 24, 253, 10.1007/s00520-015-2772-z Engler-Hüsch, 2018, In-hospital costs of community-acquired colonization with multidrug-resistant organisms at a German teaching hospital, BMC Health Serv Res, 18, 737, 10.1186/s12913-018-3549-0